IND clearance marks the first ever cellular rejuvenation therapy using partial epigenetic reprogramming to reach human ...
Imagion Biosystems has submitted an Investigational New drug Application with the US FDA for its MagSense imaging agent for breast ... Read More The post Imagion Biosystems lodges IND application for ...
HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...
BOSTON, Mass, April 01, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today ...